SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000897069-20-000396
Filing Date
2020-10-13
Accepted
2020-10-13 10:08:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 cmw236.htm SC 13D 63139
  Complete submission text file 0000897069-20-000396.txt   64502
Mailing Address 8850 STANFORD BOULEVARD SUITE 2500 COLUMBIA MD 21045
Business Address
Young David (Filed by) CIK: 0001378166 (see all company filings)

Type: SC 13D

Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Subject) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90420 | Film No.: 201235074
SIC: 2834 Pharmaceutical Preparations